Vontobel Asset Management Inc Abbott Laboratories Transaction History

Vontobel Asset Management Inc

$16.5 Billion
Q1 2024

A detailed history of Vontobel Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Vontobel Asset Management Inc holds 5,971,126 shares of ABT stock, worth $764 Million. This represents 4.11% of its overall portfolio holdings.

Number of Shares

5,971,126

Previous 6,163,414 3.12%

Holding current value

$764 Million

Previous $678 Million 0.04%

% of portfolio

4.11%

Previous 4.37%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $21.1 Million - $23.3 Million	-192,288 Reduced 3.12%	5,971,126 $679 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $56.4 Million - $69.1 Million	625,670 Added 11.3%	6,163,414 $678 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $41.7 Million - $50.1 Million	436,893 Added 8.57%	5,537,744 $536 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $102 Million - $113 Million	1,008,350 Added 24.64%	5,100,851 $556 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $2.21 Million - $2.6 Million	22,799 Added 0.56%	4,092,501 $414 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $33 Million - $38.8 Million	347,626 Added 9.34%	4,069,702 $447 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $108 Million - $125 Million	1,113,151 Added 42.67%	3,722,076 $393 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $79.6 Million - $96.2 Million	779,587 Added 42.62%	2,608,925 $302 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $86.3 Million - $105 Million	-757,275 Reduced 29.28%	1,829,338 $227 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $202 Million - $247 Million	-1,748,257 Reduced 40.33%	2,586,613 $381 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $3.21 Million - $3.56 Million	-27,558 Reduced 0.63%	4,334,870 $532 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $354 Million - $416 Million	3,343,066 Added 327.96%	4,362,428 $522 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $30.2 Million - $35.6 Million	277,744 Added 37.45%	1,019,362 $126 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $973,875 - $1.06 Million	9,275 Added 1.27%	741,618 $85.8 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $4.04 Million - $4.91 Million	44,123 Added 6.41%	732,343 $84.9 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $458,960 - $587,412	5,994 Added 0.88%	688,220 $67.5 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $42.3 Million - $61.8 Million	672,724 Added 7079.81%	682,226 $58.4 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $27,242 - $30,327	-347 Reduced 3.52%	9,502 $825,000
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $9,166 - $9,938	112 Added 1.15%	9,849 $825,000
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $26,382 - $30,770	-362 Reduced 3.58%	9,737 $820,000
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $105 Million - $126 Million	-1,578,814 Reduced 99.36%	10,099 $805,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $17.4 Million - $19.7 Million	-264,870 Reduced 14.29%	1,588,913 $119 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $329,651 - $397,684	5,421 Added 0.29%	1,853,783 $140 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $4.87 Million - $5.37 Million	-84,522 Reduced 4.37%	1,848,362 $116 Million
Q1 2018 Apr 09, 2018	SELL	$56.27 - $63.62 $66.9 Million - $75.6 Million	-1,188,476 Reduced 38.08%	1,932,884 $118 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $713,997 - $764,408	-13,301 Reduced 0.42%	3,121,360 $184 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $151 Million - $168 Million	3,134,661	3,134,661 $173 Million

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Asset Management Inc with notifications on news.

Account

Vontobel Asset Management Inc Abbott Laboratories Transaction History